Bustillo, Julio Q.

HRN: 15-44-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/18/2026
03/25/2026
IV
600mg
Every 6hrs
S/P BKA, Left
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: